Cadrenal Therapeutics, Inc. Common Stock Cash Flow Reinvestment Rate

Latest as of September 2022: 2.25x

Cadrenal Therapeutics, Inc. Common Stock cash flow reinvestment rate. Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a Cash Flow Reinvestment Rate of 2.25x as of September 2022, reinvesting $2.28K (capex $2.28K ) from operating cash flow of $1.01K. Explore CVKD cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

2.25x
(Capex + Investments) / Operating CF

Total Reinvested

$2.28K
Capex + Investments

Operating Cash Flow

$1.01K
USD

Capital Expenditures

$2.28K
USD

Cadrenal Therapeutics, Inc. Common Stock Cash Flow Reinvestment Rate by Year (None–None)

Cadrenal Therapeutics, Inc. Common Stock cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Cadrenal Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see cash flow conversion of Cadrenal Therapeutics, Inc. Common Stock.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow